enVVeno Medical Corporation (NASDAQ:NVNO) Shares Bought by Geode Capital Management LLC

Geode Capital Management LLC grew its position in enVVeno Medical Corporation (NASDAQ:NVNO) by 7.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 150,676 shares of the company’s stock after acquiring an additional 10,902 shares during the period. Geode Capital Management LLC owned about 0.86% of enVVeno Medical worth $506,000 at the end of the most recent quarter.

Separately, Maven Securities LTD purchased a new stake in enVVeno Medical in the 3rd quarter valued at approximately $295,000. 34.71% of the stock is currently owned by institutional investors.

enVVeno Medical Trading Down 3.6 %

NASDAQ NVNO opened at $3.24 on Friday. The stock has a market capitalization of $56.82 million, a price-to-earnings ratio of -2.51 and a beta of 1.21. The business’s 50 day moving average is $3.16 and its two-hundred day moving average is $4.18. enVVeno Medical Corporation has a 12-month low of $2.45 and a 12-month high of $6.97.

enVVeno Medical (NASDAQ:NVNO) last announced its quarterly earnings data on Thursday, October 31st. The company reported ($0.35) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.02). Equities analysts forecast that enVVeno Medical Corporation will post -1.3 earnings per share for the current fiscal year.

enVVeno Medical Profile

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).